The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 No. 1073 (W. 241)

SCHEDULE 3 E+W Procedures to be followed by Local Health Boards to determine applications under the Regulations

PART 2 E+W Determination of controlled localities

Imposition of conditions E+W

6.  Where a Local Health Board determines whether or not any particular area within the area for which it is established is, because it is rural in character, a controlled locality or part of a controlled locality it—

(a) must consider whether the provision of—

(i) primary medical services by a provider of such services (other than itself),

(ii) pharmaceutical services by an NHS pharmacist or NHS appliance contractor,

(iii) local pharmaceutical services provided under a pilot scheme, or

(iv) pharmaceutical services by a doctor,

is likely to be adversely affected as a consequence of that determination, and

(b) may, where it is of the opinion that any of those services are likely to be adversely affected, impose conditions to postpone, for such period as it thinks fit, the making or termination of arrangements under regulation 26 (arrangements for the provision of pharmaceutical services by doctors) or equivalent provision under the GMS Regulations for the provision by a doctor or GMS contractor of pharmaceutical services or dispensing services to patients on the relevant patient list.

Commencement Information

I1 Sch. 3 para. 6 in force at 1.10.2020, see reg. 1(2)(b)